SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-19-000946
Filing Date
2019-05-21
Accepted
2019-05-21 12:20:20
Documents
8
Period of Report
2019-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 17180
2 EX-99.1 lxrp_ex991.htm EX-99.1 16824
3 EX-99.2 lxrp_ex992.htm EX-99.2 11871
4 lxrp_ex991img1.jpg GRAPHIC 69256
5 lxrp_ex991img2.jpg GRAPHIC 3158
6 lxrp_ex991img3.jpg GRAPHIC 2975
7 lxrp_ex992img1.jpg GRAPHIC 3158
8 lxrp_ex992img2.jpg GRAPHIC 2975
  Complete submission text file 0001640334-19-000946.txt   160065
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 19841597
SIC: 1000 Metal Mining